Skip to content

Effect of intravenous hydrocortisone in patients with septic shock

Effect of intravenous hydrocortisone in patients with refractory septic shock admitted in Imam Reza hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014080211956N2
Enrollment
160
Registered
2014-10-19
Start date
2014-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock. Septic shock

Interventions

Intervention 1: Hydrocortisone administration every 6 hours for 7 days in intervention group. Intervention 2: Placebo (normal saline solution 0.9%) administration every 6 hours for 7 days in control g
Treatment - Drugs
Placebo
Hydrocortisone administration every 6 hours for 7 days in intervention group
Placebo (normal saline solution 0.9%) administration every 6 hours for 7 days in control group

Sponsors

Mashhad University of medical Siences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients above eighteen who admitted in Imam Reza Hospital of Mashad with diagnosis of septic shock and do not respond to vasopressor therapy more than 60 minutes are included. Those who suffer from adrenal insufficiency before admission or had tuberculosis or had been treated with ketoconazole or estrogens are excluded. Those with no consent with the plan are also excluded

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mortality in 28 days. Timepoint: During 28 days. Method of measurement: Death records.

Secondary

MeasureTime frame
Response to vasopressor. Timepoint: The time that there is no need to vasopressor. Method of measurement: Normal central vein pressure (6-12 Cm H2O), mean arterial pressure more than 65 mmHg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Azadeh Mahmoudi Gharaee

Mashhad University of Medical Sciences

mahmoudia913@mums.ac.ir+98 51 3852 5312

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026